Histone Methyltransferase
Histone Methyltransferase(组蛋白甲基转移酶)
Histone methyltransferases are a group of enzymes that catalyze the methylation of histone lysine and arginine by adding methyl groups to specific histone arginine or lysine residues. Histone methyltransferaes can be classified into 3 classes, including SET domain lysine methyltransferases, non-SET domain lysine methyltransferases and arginine methyltransferases (PRMTs), all of which use S-adenosylmethionine as a cosubstrate for the transfer of the methyl group. Aberrant histone methylation has been associated with a wide range of human cancers (such as hematological malignancies), which leads to the development of novel cancer chemotherapies targeting cancer-associated histone methyltransferases (more than 20 lysine methyltransferases and 9 arginine methyltransferases in humans).
Histone Methyltransferase 相关产品(238)
- GC18650S-(5'-Adenosyl)-L-methionine (tosylate)CAS: 52248-03-0纯度: >98.00%
S-Adenosyl-L-methioninetosylate(S-Adenosylmethioninetosylate)是通过蛋氨酸腺苷转移酶的作用由蛋氨酸和ATP内源性生产的,是一种重要的具有口服活性的甲基供体。
- GC19181GSK2807 TrifluoroacetateCAS: 2245255-66-5
GSK2807 Trifluoroacetate 是一种有效的、选择性的、SAM 竞争性的 SMYD3 抑制剂,Ki 为 14 nM,IC50 为 130 nM。
- GC30530Dot1L-IN-2CAS: 1940206-71-2
Dot1L-IN-2是一种有效的,选择性的,可口服的Dot1L(一种histonemethyltransferase),IC50值和Ki值分别为0.4nM和0.08nM。
- GC32693GSK3326595 (EPZ015938)CAS: 1616392-22-3纯度: >99.50% / >99.00%
GSK3326595 (EPZ015938) 是一种具有口服活性的、有效的、选择性protein arginine methyltransferase 5(PRMT5)抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18159 | BAY-598 | 1906919-67-2 | >99.50% | |
BAY-598是一种氨基吡唑啉基的选择性小分子抑制剂,靶点为含有SET和MYND结构域的蛋白2(SMYD2),半抑制浓度(IC 50 )为27nM。 | ||||
| GC18161 | BCI-121 | 432529-82-3 | >99.00% | |
An inhibitor of SMYD3 | ||||
| GC18428 | SGC2085 (hydrochloride) | 1821908-49-9 | - | |
A PRMT4/CARM1 inhibitor | ||||
| GC18577 | CID-2818500 | 1215-07-2 | - | |
An inhibitor of PRMT1 | ||||
| GC18642 | SW155246 | 420092-79-1 | - | |
A DNA methyltransferase 1 inhibitor | ||||
| GC18650 | S-(5'-Adenosyl)-L-methionine (tosylate) | 52248-03-0 | >98.00% | |
S-Adenosyl-L-methioninetosylate(S-Adenosylmethioninetosylate)是通过蛋氨酸腺苷转移酶的作用由蛋氨酸和ATP内源性生产的,是一种重要的具有口服活性的甲基供体。 | ||||
| GC18949 | CAY10677 | 1443253-20-0 | - | |
An inhibitor of protein prenylation | ||||
| GC19130 | EED226 | 2083627-02-3 | >98.50% | |
EED226是一种强效的多梳抑制复合物2(PRC2)抑制剂,IC 50 值为22.3nM。 | ||||
| GC19141 | EPZ011989 | 1598383-40-4 | >99.50% | |
An orally bioavailable EZH2 inhibitor | ||||
| GC19149 | EZM 2302 | 1628830-21-6 | >99.00% | |
EZM 2302是一种对CARM1有效的且具有选择性的抑制剂,其IC 50 值为6nM。 | ||||
| GC19181 | GSK2807 Trifluoroacetate | 2245255-66-5 | - | |
GSK2807 Trifluoroacetate 是一种有效的、选择性的、SAM 竞争性的 SMYD3 抑制剂,Ki 为 14 nM,IC50 为 130 nM。 | ||||
| GC19211 | JQEZ5 | 1913252-04-6 | >98.00% | |
An EZH2 inhibitor | ||||
| GC19329 | SGC2085 | 1821908-48-8 | >99.50% | |
A PRMT4/CARM1 inhibitor | ||||
| GC19388 | XY1 | 1624117-53-8 | >99.00% | |
A negative control for SGC707 | ||||
| GC19465 | JNJ-64619178 | 2086772-26-9 | >99.50% | |
A PRMT5 inhibitor | ||||
| GC19849 | SGC3027 | 2624313-13-7 | >98.50% / >98.00% | |
A prodrug form of SGC8158 | ||||
| GC25159 | BMF-219 | 2448172-22-1 | >98.00% | |
BMF-219是一种高选择性和不可逆的menin抑制剂,在小鼠模型中具有良好的抑制效果 。 | ||||
| GC30503 | A-893 | 1868232-32-9 | - | |
A-893是一个有细胞活性的,SMYD2的抑制剂,其IC50值为2.8nM。 | ||||
| GC30530 | Dot1L-IN-2 | 1940206-71-2 | - | |
Dot1L-IN-2是一种有效的,选择性的,可口服的Dot1L(一种histonemethyltransferase),IC50值和Ki值分别为0.4nM和0.08nM。 | ||||
| GC32693 | GSK3326595 (EPZ015938) | 1616392-22-3 | >99.50% / >99.00% | |
GSK3326595 (EPZ015938) 是一种具有口服活性的、有效的、选择性protein arginine methyltransferase 5(PRMT5)抑制剂。 | ||||
| GC32861 | A-196 | 1982372-88-2 | >98.00% | |
A selective inhibitor of SUV420H1 and SUV420H2 | ||||
| GC32977 | PF-06726304 | 1616287-82-1 | >99.50% | |
PF-06726304是有效,选择性的EZH2抑制剂,Ki值为0.7nM。 | ||||
| GC32988 | BRD9539 | 1374601-41-8 | >99.00% | |
An inhibitor of EHMT2/G9a and PRC2 in enzyme assays | ||||
| GC33184 | LLY-283 | 2040291-27-6 | >99.00% | |
A PRMT5 inhibitor | ||||
